EEF1AKNMT

Across TCGA pan-cancer cohorts, EEF1AKNMT mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated EEF1AKNMT data layer compared with 25 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher EEF1AKNMT mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated EEF1AKNMT expression acts as an unfavorable survival marker, although some lineages such as PDAC and LUAD show a favorable association.

CCRCC, HNSC, and PDAC are the cancer types where EEF1AKNMT mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	DFS	Tertile	IV	0.137	0.815	.024	20	view →
HNSC	DFS	Median	All	0.909	0.978	.012	16	view →
PDAC	DFS	Median	IV	0.785	0.214	.006	9	view →
GBM	DFS	Quartile	All	0.204	0.520	.002	6	view →
LUAD	OS	Tertile	All	0.936	0.790	.028	4	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

EEF1AKNMT–CCRCC (DFS)

Open the CCRCC breakdown →